Expert Meeting on Disease Management Outcomes Measurement, 71412 [07-6057]

Download as PDF 71412 Federal Register / Vol. 72, No. 241 / Monday, December 17, 2007 / Notices percent of the voting shares of Bradford Bancshares, Inc., and thereby indirectly acquire voting shares of The Bank of Bradford, both of Bradford, Tennessee. 2. First Banks, Inc., St. Louis, Missouri; to acquire an additional 1.21 percent, for a total of 24.99 percent, of the voting shares of Community West Bancshares, and thereby indirectly acquire additional voting shares of Community West Bank, National Association, both of Goleta, California. C. Federal Reserve Bank of Kansas City (Todd Offenbacker, Assistant Vice President) 925 Grand Avenue, Kansas City, Missouri 64198–0001: 1. Central Financial Corporation, Hutchinson, Kansas; to retain 6.04 percent of the voting shares of Valley Capital Bank, N.A., Mesa, Arizona. Board of Governors of the Federal Reserve System, December 12, 2007. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc.E7–24314 Filed 12–14–07; 8:45 am] BILLING CODE 6210–01–S GENERAL SERVICES ADMINISTRATION [PBS–N02] Notice of Availability of the Draft Environmental Assessment and Wetland Involvement for the Transformation of Facilities and Infrastructure for the Non-Nuclear Production Activities Conducted at the National Nuclear Security Administration’s Kansas City Plant at Kansas City, MO ebenthall on PROD1PC69 with NOTICES SUMMARY: GSA published a notice in the Federal Register at 72 FR 69690 on Monday, December 10, 2007, concerning the National Nuclear Security Administration’s Kansas City Plant at Kansas City, MO. The document contained an incorrect state abbreviation and date format. DATES: December 17, 2007. FOR FURTHER INFORMATION CONTACT: Ms. Diedra Wingate at (202) 501–4755, GSA, Regulatory Secretariat. Corrections In the notice document FR Doc. E7– 23843 on page 69690 make the following corrections: In the first column, the last line of the notice title ‘‘Kansas City, MI’’ should read ‘‘Kansas City, MO’’. In the second column, under the heading DATES, in the third line, ‘‘Monday, January 14th’’, 15:28 Dec 14, 2007 Diedra Wingate, Regulatory Secretariat. [FR Doc. E7–24354 Filed 12–14–07; 8:45 am] BILLING CODE 6820–EP–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Expert Meeting on Disease Management Outcomes Measurement Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation. ACTION: Notice of meeting. AGENCY: SUMMARY: This notice announces the date and location of the Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation (HHS/ASPE) Expert Meeting on Disease Management Outcomes Measurement. The objective of the meeting is to convene a panel of experts from government, academia, and private industry to discuss measurement of the impact of disease management on health outcomes and costs of care, with a focus on potential for public sector programs. DATES: Wednesday, January 16, 2008, from 9 a.m. to 5 p.m. Eastern Time. ADDRESSES: The Expert Meeting will be held at 1200 South Hayes Street, Room 4204, Arlington, VA 22202–5050. Telephone: (703) 413–1100. Registration procedures are described in the SUPPLEMENTARY INFORMATION section below. FOR FURTHER INFORMATION CONTACT: General Services Administration (GSA). ACTION: Correction. AGENCIES: VerDate Aug<31>2005 should read ‘‘Monday, January 14, 2008’’. Jkt 214001 Adelle Simmons, Office of the Assistant Secretary for Planning and Evaluation, 200 Independence Avenue, SW., Washington, DC 20201. Telephone: (202) 690–5924. SUPPLEMENTARY INFORMATION: I. Background In the face of increasing health care costs, evidence of the need for systemwide health care quality improvement, and an aging population, disease management seems an intuitively appealing way to improve the coordination and quality of care, and ultimately improve health outcomes. In broad terms, disease management refers to a system of coordinated health care interventions and communications to help patients address chronic health conditions. Commercial health plans and large employers are embracing this strategy, and public purchasers of health care services including the Centers for Medicare and Medicaid Services (CMS) PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 have implemented demonstration programs to evaluate disease management for certain conditions. Questions about the effectiveness of disease management remain, in part, because the evaluation methods of vendors of large, population-based programs often lack scientific validity. Conversely, vendors often argue that scientifically credible approaches, like a randomized controlled experiment that the Medicare Health Support pilot uses, are not feasible for routine operation. Thus, the lack of universally accepted yet feasible evaluation methods are a major obstacle to adopting and improving disease management, because potential purchasers of such programs find it hard to identify the best program design and to monitor its success. A primary goal of this meeting is to consider the variety of disease management programs and identify strategies to improve the assessment of their impact on individuals with multiple chronic conditions. II. Registration The meeting is open to the public, and pre-registration is encouraged. Seating capacity is limited, so registration will be accepted on a firstcome, first-served basis. Registration can be completed by sending an e-mail message to Ms. Emily Taylor of the RAND Corporation at etaylor@rand.org (The RAND Corporation is the Contractor to HHS/ASPE to provide logistical support for the Expert Meeting.) To register by telephone, contact Ms. Taylor at (703) 413–1100 ext. 5793. The following information must be provided when registering: Name, Company/Organization, and address. A RAND Corporation staff member will confirm registrations by mail, e-mail, or fax. Note: In the event that the meeting must be canceled due to inclement weather, the meeting will be held at a later date, and registrants will be notified by RAND. III. Special Accommodations Individuals who are hearing- or visually-impaired and have special requirements or a condition that requires special assistance must request accommodation when registering for the meeting in order to ensure that accommodations will be made. Dated: December 12, 2007. Mary M. McGeein, Principal Deputy Assistant Secretary for Planning and Evaluation, Department of Health and Human Services. [FR Doc. 07–6057 Filed 12–14–07; 8:45 am] BILLING CODE 4150–24–M E:\FR\FM\17DEN1.SGM 17DEN1

Agencies

[Federal Register Volume 72, Number 241 (Monday, December 17, 2007)]
[Notices]
[Page 71412]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-6057]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Expert Meeting on Disease Management Outcomes Measurement

AGENCY: Department of Health and Human Services, Office of the 
Assistant Secretary for Planning and Evaluation.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the date and location of the Department 
of Health and Human Services, Office of the Assistant Secretary for 
Planning and Evaluation (HHS/ASPE) Expert Meeting on Disease Management 
Outcomes Measurement. The objective of the meeting is to convene a 
panel of experts from government, academia, and private industry to 
discuss measurement of the impact of disease management on health 
outcomes and costs of care, with a focus on potential for public sector 
programs.

DATES: Wednesday, January 16, 2008, from 9 a.m. to 5 p.m. Eastern Time.

ADDRESSES: The Expert Meeting will be held at 1200 South Hayes Street, 
Room 4204, Arlington, VA 22202-5050. Telephone: (703) 413-1100. 
Registration procedures are described in the SUPPLEMENTARY INFORMATION 
section below.

FOR FURTHER INFORMATION CONTACT: Adelle Simmons, Office of the 
Assistant Secretary for Planning and Evaluation, 200 Independence 
Avenue, SW., Washington, DC 20201. Telephone: (202) 690-5924.

SUPPLEMENTARY INFORMATION:

I. Background

    In the face of increasing health care costs, evidence of the need 
for system-wide health care quality improvement, and an aging 
population, disease management seems an intuitively appealing way to 
improve the coordination and quality of care, and ultimately improve 
health outcomes. In broad terms, disease management refers to a system 
of coordinated health care interventions and communications to help 
patients address chronic health conditions. Commercial health plans and 
large employers are embracing this strategy, and public purchasers of 
health care services including the Centers for Medicare and Medicaid 
Services (CMS) have implemented demonstration programs to evaluate 
disease management for certain conditions.
    Questions about the effectiveness of disease management remain, in 
part, because the evaluation methods of vendors of large, population-
based programs often lack scientific validity. Conversely, vendors 
often argue that scientifically credible approaches, like a randomized 
controlled experiment that the Medicare Health Support pilot uses, are 
not feasible for routine operation. Thus, the lack of universally 
accepted yet feasible evaluation methods are a major obstacle to 
adopting and improving disease management, because potential purchasers 
of such programs find it hard to identify the best program design and 
to monitor its success. A primary goal of this meeting is to consider 
the variety of disease management programs and identify strategies to 
improve the assessment of their impact on individuals with multiple 
chronic conditions.

II. Registration

    The meeting is open to the public, and pre-registration is 
encouraged. Seating capacity is limited, so registration will be 
accepted on a first-come, first-served basis. Registration can be 
completed by sending an e-mail message to Ms. Emily Taylor of the RAND 
Corporation at etaylor@rand.org (The RAND Corporation is the Contractor 
to HHS/ASPE to provide logistical support for the Expert Meeting.) To 
register by telephone, contact Ms. Taylor at (703) 413-1100 ext. 5793.
    The following information must be provided when registering: Name, 
Company/Organization, and address. A RAND Corporation staff member will 
confirm registrations by mail, e-mail, or fax.

    Note: In the event that the meeting must be canceled due to 
inclement weather, the meeting will be held at a later date, and 
registrants will be notified by RAND.

III. Special Accommodations

    Individuals who are hearing- or visually-impaired and have special 
requirements or a condition that requires special assistance must 
request accommodation when registering for the meeting in order to 
ensure that accommodations will be made.

    Dated: December 12, 2007.
Mary M. McGeein,
Principal Deputy Assistant Secretary for Planning and Evaluation, 
Department of Health and Human Services.
[FR Doc. 07-6057 Filed 12-14-07; 8:45 am]
BILLING CODE 4150-24-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.